Distinct glycoforms of human α1-acid glycoprotein have comparable synthesis rates: A [13C]valine-labelling study in healthy humans

Glycoconjugate Journal

Volumn 20, Issue 2, 2003, Pages 99-105

  Poland, Dennis C W ^a   Kulik, Willem ^a,b   Van Dijk, Willem ^a   Hallemeesch, Marcella M ^a   Jakobs, Cornelis ^a   De Meer, Kees ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Acute phase glycoprotein; Fractional synthesis rate; GC c IRMS; Pectrometry; Stable isotope; Valine; 1 acid glycoproteln; 1 acid glycoproteln glycoforms

Indexed keywords

ACUTE PHASE PROTEIN; CARBON 13; CONCANAVALIN A; GLYCOPROTEIN; ISOPROTEIN; OROSOMUCOID; STABLE ISOTOPE; VALINE;

ADULT; AMINO ACID METABOLISM; ARTICLE; CONTROLLED STUDY; GAS CHROMATOGRAPHY; GLYCOPROTEIN SYNTHESIS; HUMAN; HUMAN EXPERIMENT; ISOTOPE LABELING; LIVER METABOLISM; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REACTION ANALYSIS;

ALEURIA AURANTIA;

EID: 1642486521     PISSN: 02820080     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:GLYC.0000018584.66712.2c     Document Type: Article

References (38)

1. 1-Acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties, Cytokine Growth Factor Rev 14, 25-34 (2003).
2. Kushner I, The phenomenon of the acute-phase response, Ann NY Acad Sci 389, 39-48 (1982).
3. Schmid K, Nimberg RB, Kimura A, Yamaguchi H, Binette JP, The carbohydrate units of alphal-acid glycoprotein, Biochim Biophys Acta 492, 291-302 (1977).
4. Treuheit MJ, Costello CE, Halsall HB, Analysis of the five glycosylation sites of human AGP, Biochem J 283, 105-12 (1992).
5. Wieruszeski JM, Fournet B, Konan D, Durand G, 400-MHz 1H-NMR spectroscopy of fucosylated tetrasialyloligosaccharides from normal and cirrhotic AGP, FEBS Lett 238, 390-4 (1988).
6. Brinkman-Van der Linden ECM, Mollicones R, Oriol R, Larson G, Van den Eijnden DH, Van Dijk W, A Missence mutation in the FUT6 gene results in total absence of α3-fucosylation of human alpha1-acid glycoprotein, J Biol Chem 271, 14492-5 (1996).
7. 1-acid glycoprotein (orosomucoid) in human sera, J Exp Med 177, 657-66 (1993).
8. 1-acid glycoprotein (orosomucoid) in health and disease: occurrence, regulation and possible functional implications, Trends Glycosci Glycotechnol 53, 235-45 (1998).
9. 1-Acid glycoprotein: a natural occurring antiinflammatory molecule? Adv Exp Med Biol 376, 223-9 (1995).
10. 1-acid glycoprotein in septic shock: changes in degree of branching and in expression of sialyl Lewis-x groups, Glycoconjugate J 13, 27-31 (1996).
11. Havenaar EC, Dolhain RJEM, Turner GA, Goodarzi MT, Van Ommen EC, Breedveld FC, Van Dijk W, Do synovial fluid acute phase proteins from patients with rheumatoid arthritis originate from serum, Glycoconjugate J 14, 457-65 (1997).
12. Pos O, Van der Stelt ME, Wolbink GJ, Nijsten MWN, Van der Tempel GL, Van Dijk W, Changes in the serum concentration and glycosylation of apacid glycoprotein and alpha1-protease inhibitor in severely burned patients: relation to interleukin-6 levels, Clin Exp Immunol 82, 579-82 (1990).
13. 1-acid glycoprotein, Pharmacogenetics 6, 403-15 (1996).
14. 1-acid glycoprotein and serum retinol-binding protein and its relatives, FASEB J 1, 209-14 (1987).
15. Costello M, Fiedel BA, Gewurz H, Inhibition of platelet aggregation by native and desialylated alpha1-acid glycoprotein, Nature 281, 677-8 (1979).
16. 1-acid glycoprotein: studies with primary human hepatocyte cultures and rats, Inflammation 13/4, 415-427 (1989).
17. 1-Acid glycoprotein reduces local and remote injuries after intestinal ischemia in the rat, Am J Physiol 273, G1031-5 (1997).
18. 1-acid glycoprotein (AGP) is more effective in modulation of lymphocyte proliferation than Con A-reactive AGP serum variants, Inflammation 14, 133-41 (1990).
19. X epitopes do not occur on acute phase proteins in mice: relationship to the absence of α3-fucosyltransferase in the liver, Glycoconjugate J 15, 389-95 (1998).
20. McGuire EAM, Helderman JH, Tobin JD, Andres R, Berman M, Effects of arterial versus venous sampling on analysis of glucose kinetics in man, J Appl Physiol 41, 565-7 (1976).
21. Mancini G, Carbonara AO, Heremans JF, A single radial diffusion method for the immunological quantification of proteins, Immunochemistry 2, 235-54 (1965).
22. Kulik W, Jacobs C, De Meer K, Determination of extracellular and intracellular enrichments of α-[1-13C]ketoisovalerate using enzymatically converted [1-13C]valine standardization curves and gas chromatography-mass spectrometry, J Chromatogr B 729, 211-6 (1999).
23. 13C values of valine in protein hydrolysate by gas chromatography-combustion isotope ratio mass spectrometry, J Chromatogr B 710, 37-47 (1998).
24. Schachter H, The joys of HexNAc. The synthesis and function of N- and O-glycan branches, Glycoconjugate J 17, 465-83 (2000).
25. 1-acid glycoprotein (AGP): studies with human sera, primary cultures of human hepatocytes and transgenic mice, Biochem J 276, 343-7 (1991).
26. Baumann H, Gauldie J, The acute phase response, Immunol Today 15, 74-80 (1994).
27. Dalziel M, Lemaire S, Ewing J, Kobayashi L, Lau JT, Hepatic acute phase induction of murine β-galacloside α2,6-sialyltransferase (ST6Gal I) is IL-6 dependent and mediated by elevation of exon H-containing class of transcripts, Glycobiology 9, 1003-8 (1999).
28. Jamieson JC, McCaffrey G, Harder PG, Sialyltransferase: a novel acute-phase reactant, Comp Biochem Physiol B 105, 29-33 (1993).
29. Lombart C, Sturgess J, Schachter H, The effect of turpentine-induced inflammation on rat liver glycosyltransferases and Golgi complex ultrastructure, Biochim Biophys Acta 629, 1-12 (1980).
30. Memon RA, Holleran WM, Uchida Y, Moser AH, Ichikawa S, Hirabayashi Y, Grunfeld C, Feingold KR, Regulation of glycosphingolipid metabolism in liver during the acute phase response, J Biol Chem 274, 19707-13 (1999).
31. Tanaka S, Yazawa S, Noguchi K, Nishimura T, Miyanaga K, Kochibe N, Poland DCW, Van Dijk W, Matta KL, Molecular analysis of plasma α1, 3-fucosyltransferase deficiency and developmenl of the methods of genotyping, Exptl Clin Immunogen 18, 1-12 (2001).
32. Van Dijk W, Boers W, Sala M, Lasthuis AM, Mookerjea S, Activity and secretion of sialyltransferase in primary monolayer cultures of rat hepatocytes cultured with and without dexamethasone, Biochem Cell Biol 64, 79-84 (1986).
33. Jahoor F, Gazzard B, Philips G, Sharpstone D, Delrosario M, Frazer ME, Heard W, Smith R, Jackson A, The acute phase response to human immunodeficiency virus infection in human subjects, Am J Physiol 276, E1092-8 (1999).
34. Mansoor O, Cayol M, Gachon P, Boirie Y, Schoeffler P, Obled C, Beaufrere B, Albumin and fibrinogen synthesis increase while muscle protein synthesis decreases in head-injured patients, Am J Physiol 273, E898-E902 (1997).
35. Preston T, Slater C, McMillan DC, Falconer JS, Shenkin A, Fearon KC. Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response, J Nutr 128, 1355-60 (1998).
36. De Sain-van der Velden MGM, Kaysen GA, De Meer K, Stellaard F, Voorbij AM, Reijngoud DJ, Rabelink TJ, Koomans HA, Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: measurements with stable isotopes, Kidney Int 53, 181-8 (1998).
37. Foster DM, Barrett PH, Toffolo G, Beltz WF, Cobelli C, Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data, J Lipid Res 34, 2193-205 (1993).
38. 1-acid glycoprotein and β-N-acetylhexosaminidase, Biochem Biophys Res Commun 130, 30-6 (1985).